Variant report

Variant	nsv969354
Chromosome Location	chr6:25139819-25141640
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:57)
CpG islands
(count:244)
Chromatin interactive
region (count:1)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:57 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr6:25139900-25140050	HCPEpiC	choroid plexus:	n/a	n/a
2	CTCF	chr6:25139920-25140070	NHEK	skin:	n/a	n/a
3	E2F6	chr6:25139837-25140062	K562	blood:	n/a	n/a
4	HEY1	chr6:25139847-25140023	HepG2	liver:	n/a	chr6:25139984-25139999
5	HEY1	chr6:25139800-25140117	K562	blood:	n/a	chr6:25139984-25139999
6	HEY1	chr6:25139815-25140093	K562	blood:	n/a	chr6:25139984-25139999
7	HEY1	chr6:25139807-25140113	HepG2	liver:	n/a	chr6:25139984-25139999
8	MAX	chr6:25139782-25140131	K562	blood:	n/a	n/a
9	MAX	chr6:25139846-25140066	K562	blood:	n/a	n/a
10	POLR2A	chr6:25139910-25140066	HUVEC	blood vessel:	n/a	n/a
11	POLR2A	chr6:25139896-25139969	A549	lung:	n/a	n/a
12	POLR2A	chr6:25139919-25140133	MCF-7	breast:	n/a	n/a
13	POLR2A	chr6:25139841-25140077	H1-hESC	embryonic stem cell:	n/a	n/a
14	POLR2A	chr6:25139801-25140106	GM12891	blood:	n/a	n/a
15	POLR2A	chr6:25139849-25139908	HUVEC	blood vessel:	n/a	n/a
16	POLR2A	chr6:25139928-25140128	MCF-7	breast:	n/a	n/a
17	POLR2A	chr6:25139757-25140171	GM12892	blood:	n/a	n/a
18	POLR2A	chr6:25139792-25140126	SK-N-MC	brain:	n/a	n/a
19	POLR2A	chr6:25139861-25140120	K562	blood:	n/a	n/a
20	POLR2A	chr6:25139866-25140225	GM12878	blood:	n/a	n/a
21	POLR2A	chr6:25139746-25140211	ProgFib	skin:	n/a	n/a
22	POLR2A	chr6:25139895-25139995	A549	lung:	n/a	n/a
23	POLR2A	chr6:25139880-25140031	A549	lung:	n/a	n/a
24	POLR2A	chr6:25139786-25140286	GM12892	blood:	n/a	n/a
25	POLR2A	chr6:25139836-25140104	A549	lung:	n/a	n/a
26	POLR2A	chr6:25139910-25140110	H1-hESC	embryonic stem cell:	n/a	n/a
27	POLR2A	chr6:25139837-25140106	GM12878	blood:	n/a	n/a
28	POLR2A	chr6:25139861-25140028	HepG2	liver:	n/a	n/a
29	POLR2A	chr6:25139928-25140129	MCF-7	breast:	n/a	n/a
30	POLR2A	chr6:25139840-25140067	GM12891	blood:	n/a	n/a
31	POLR2A	chr6:25139872-25139980	HepG2	liver:	n/a	n/a
32	POLR2A	chr6:25139923-25139954	A549	lung:	n/a	n/a
33	POLR2A	chr6:25139854-25140184	GM12878	blood:	n/a	n/a
34	POLR2A	chr6:25139913-25139962	Hela-S3	cervix:	n/a	n/a
35	POLR2A	chr6:25139839-25140077	Hela-S3	cervix:	n/a	n/a
36	POLR2A	chr6:25139943-25139951	Gliobla	brain:	n/a	n/a
37	POLR2A	chr6:25139815-25140115	Hela-S3	cervix:	n/a	n/a
38	POLR2A	chr6:25139792-25140211	GM12878	blood:	n/a	n/a
39	POLR2A	chr6:25139869-25139989	H1-hESC	embryonic stem cell:	n/a	n/a
40	SIN3AK20	chr6:25140027-25140152	HepG2	liver:	n/a	n/a
41	TAF1	chr6:25139827-25140122	H1-hESC	embryonic stem cell:	n/a	n/a
42	TAF1	chr6:25139832-25140085	GM12891	blood:	n/a	n/a
43	TAF1	chr6:25139819-25140214	H1-hESC	embryonic stem cell:	n/a	n/a
44	TAF1	chr6:25139822-25140125	GM12891	blood:	n/a	n/a
45	TAF1	chr6:25139866-25140028	HepG2	liver:	n/a	n/a
46	TAF1	chr6:25139843-25140070	GM12878	blood:	n/a	n/a
47	TAF1	chr6:25139808-25140071	GM12892	blood:	n/a	n/a
48	YY1	chr6:25139770-25140091	GM12892	blood:	n/a	chr6:25139928-25139936 chr6:25139917-25139939 chr6:25139927-25139939 chr6:25139929-25139939 chr6:25139924-25139940
49	YY1	chr6:25139814-25140070	GM12878	blood:	n/a	chr6:25139928-25139936 chr6:25139917-25139939 chr6:25139927-25139939 chr6:25139929-25139939 chr6:25139924-25139940
50	YY1	chr6:25139770-25140069	GM12878	blood:	n/a	chr6:25139928-25139936 chr6:25139917-25139939 chr6:25139927-25139939 chr6:25139929-25139939 chr6:25139924-25139940

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:25140063-25140113	GM12891	blood:	n/a
2	chr6:25140377-25140427	GM06990	blood:	n/a
3	chr6:25140136-25140186	AG04450	lung:	fetal
4	chr6:25140136-25140186	HL-60	blood:	n/a
5	chr6:25140063-25140113	NT2-D1	testis:	n/a
6	chr6:25140136-25140186	HepG2	liver:	n/a
7	chr6:25140091-25140141	Jurkat	blood:	n/a
8	chr6:25140377-25140427	MCF-7	breast:	n/a
9	chr6:25140377-25140427	NT2-D1	testis:	n/a
10	chr6:25140063-25140113	ovcar-3	ovarian:	n/a
11	chr6:25140091-25140141	HCPEpiC	choroid plexus:	n/a
12	chr6:25140063-25140113	HRCEpiC	kidney:	n/a
13	chr6:25140377-25140427	HRCEpiC	kidney:	n/a
14	chr6:25140377-25140427	AG10803	skin:	n/a
15	chr6:25140091-25140141	Hepatocyte	liver:	n/a
16	chr6:25140377-25140427	AoSMC	blood vessel:	n/a
17	chr6:25140136-25140186	NHBE	bronchial:	n/a
18	chr6:25140063-25140113	AG09319	gingival:	n/a
19	chr6:25140377-25140427	GM12892	blood:	n/a
20	chr6:25140063-25140113	RPTEC	kidney:	n/a
21	chr6:25140136-25140186	HRE	kidney:	n/a
22	chr6:25140377-25140427	A549	lung:	n/a
23	chr6:25140377-25140427	HNPCEpiC	eye:	n/a
24	chr6:25140063-25140113	AG04450	lung:	fetal
25	chr6:25140063-25140113	H1-hESC	embryonic stem cell:	embryo
26	chr6:25140063-25140113	GM19239	blood:	n/a
27	chr6:25140377-25140427	HEK293	kidney:	embryo
28	chr6:25140063-25140113	HIPEpiC	eye:	n/a
29	chr6:25140091-25140141	GM12891	blood:	n/a
30	chr6:25140091-25140141	H1-hESC	embryonic stem cell:	embryo
31	chr6:25140136-25140186	BE2_C	brain:	n/a
32	chr6:25140136-25140186	HCF	heart:	n/a
33	chr6:25140063-25140113	IMR90	lung:	fetal
34	chr6:25140377-25140427	NHBE	bronchial:	n/a
35	chr6:25140091-25140141	MCF10A-Er-Src	breast:	n/a
36	chr6:25140377-25140427	Jurkat	blood:	n/a
37	chr6:25140377-25140427	NHDF-neo	bronchial:	n/a
38	chr6:25140091-25140141	AG04450	lung:	fetal
39	chr6:25140063-25140113	T-47D	breast:	n/a
40	chr6:25140091-25140141	HL-60	blood:	n/a
41	chr6:25140136-25140186	GM19239	blood:	n/a
42	chr6:25140377-25140427	T-47D	breast:	n/a
43	chr6:25140091-25140141	NT2-D1	testis:	n/a
44	chr6:25140091-25140141	SK-N-SH	brain:	n/a
45	chr6:25140063-25140113	U87	brain:	n/a
46	chr6:25140377-25140427	BJ	skin:	n/a
47	chr6:25140063-25140113	NHDF-neo	bronchial:	n/a
48	chr6:25140063-25140113	Caco-2	colon:	n/a
49	chr6:25140136-25140186	HRPEpiC	eye:	n/a
50	chr6:25140091-25140141	BJ	skin:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr6:25138546..25140373-chr6:25141189..25143013,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000219682	TF binding region
CMAHP	TF binding region
ENSG00000219682	CpG island
CMAHP	CpG island
ENSG00000219682	chromatin interactions
ENSG00000168405	chromatin interactions

Extended variants
information (count: 99 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:99 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs79645378	chr6:25139890-25139891	Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
2	rs571181717	chr6:25139899-25139900	Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
3	rs570995080	chr6:25139914-25139915	Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs536952912	chr6:25139938-25139939	Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
5	rs192763349	chr6:25139949-25139950	Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs577481191	chr6:25140021-25140022	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs567166815	chr6:25140022-25140023	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
8	rs144867449	chr6:25140024-25140025	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
9	rs73386299	chr6:25140027-25140028	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs184124430	chr6:25140030-25140031	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
11	rs553215870	chr6:25140055-25140056	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs372272363	chr6:25140064-25140065	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
13	rs113079400	chr6:25140084-25140085	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
14	rs367903615	chr6:25140085-25140086	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
15	rs367705596	chr6:25140086-25140087	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
16	rs188305413	chr6:25140087-25140088	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
17	rs549995024	chr6:25140091-25140092	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
18	rs530258448	chr6:25140099-25140100	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
19	rs542691136	chr6:25140112-25140113	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
20	rs559149431	chr6:25140113-25140114	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
21	rs372066673	chr6:25140115-25140116	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
22	rs148522025	chr6:25140124-25140125	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
23	rs376321820	chr6:25140126-25140127	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
24	rs369935185	chr6:25140130-25140131	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
25	rs530707534	chr6:25140136-25140137	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
26	rs550509997	chr6:25140142-25140143	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
27	rs567104154	chr6:25140161-25140162	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
28	rs536094176	chr6:25140173-25140174	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
29	rs374426405	chr6:25140176-25140177	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
30	rs553151280	chr6:25140177-25140178	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
31	rs566802702	chr6:25140181-25140182	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
32	rs538934880	chr6:25140182-25140183	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
33	rs539130299	chr6:25140187-25140188	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs558980481	chr6:25140193-25140194	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs376704418	chr6:25140202-25140203	Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs192679546	chr6:25140255-25140256	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs544898536	chr6:25140257-25140258	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs368745062	chr6:25140308-25140309	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs555335056	chr6:25140349-25140350	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs184716822	chr6:25140380-25140381	Weak transcription Enhancers Active TSS	CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs189006773	chr6:25140397-25140398	Weak transcription Enhancers Active TSS	CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs9654578	chr6:25140405-25140406	Weak transcription Enhancers	CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs7757166	chr6:25140464-25140465	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs544745999	chr6:25140504-25140505	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs370579448	chr6:25140513-25140514	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs181489222	chr6:25140524-25140525	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs550447975	chr6:25140552-25140553	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs560992849	chr6:25140576-25140577	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs371937465	chr6:25140587-25140588	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs151032271	chr6:25140588-25140589	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Osteosarcoma	16790693	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Burkitt''s lymphoma	19759907	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Bladder cancer	16790693	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Lung cancer	19153074	CNVD
Breast cancer	21364760	CNVD
Cancer	21183584	CNVD
Myelofibrosis	22110671	CNVD
Williams-beuren syndrome	16971481	CNVD
Uveal melanoma	20484589	CNVD
small cell lung cancer	20016488	CNVD
Chronic lymphocytic leukemia	20421269	CNVD

Chromatin state (count:54 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:25135200-25140200	Active TSS	Right Atrium	heart
2	chr6:25136200-25140000	Active TSS	Aorta	Aorta
3	chr6:25136600-25140000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
4	chr6:25136800-25140000	Active TSS	Ovary	ovary
5	chr6:25137000-25140200	Active TSS	Psoas Muscle	Psoas
6	chr6:25138000-25140200	Active TSS	Breast Myoepithelial Primary Cells	Breast
7	chr6:25138400-25140200	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
8	chr6:25138400-25140400	Active TSS	Fetal Intestine Large	intestine
9	chr6:25138600-25140000	Active TSS	Fetal Intestine Small	intestine
10	chr6:25138800-25140000	Active TSS	Fetal Adrenal Gland	Adrenal Gland
11	chr6:25138800-25140200	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
12	chr6:25138800-25152800	Weak transcription	Lung	lung
13	chr6:25139200-25154800	Weak transcription	Placenta Amnion	Placenta Amnion
14	chr6:25139400-25140000	Weak transcription	Right Ventricle	heart
15	chr6:25139400-25140000	Flanking Active TSS	Dnd41	blood
16	chr6:25139400-25140200	Enhancers	Fetal Brain Male	brain
17	chr6:25139600-25140000	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
18	chr6:25139600-25140000	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr6:25139600-25140000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
20	chr6:25139600-25140000	Enhancers	Colon Smooth Muscle	Colon
21	chr6:25139600-25140000	Enhancers	NHLF	lung
22	chr6:25139600-25140200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
23	chr6:25139600-25140200	Enhancers	Stomach Smooth Muscle	stomach
24	chr6:25139600-25140600	Enhancers	Primary monocytes fromperipheralblood	blood
25	chr6:25139600-25141800	Weak transcription	Fetal Thymus	thymus
26	chr6:25139600-25152800	Weak transcription	Thymus	Thymus
27	chr6:25139800-25140000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr6:25139800-25140000	Enhancers	Primary hematopoietic stem cells	blood
29	chr6:25139800-25140000	Active TSS	Primary hematopoietic stem cells short term culture	blood
30	chr6:25139800-25140000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
31	chr6:25139800-25140000	Enhancers	Muscle Satellite Cultured Cells	--
32	chr6:25139800-25140000	Enhancers	Fetal Muscle Trunk	muscle
33	chr6:25139800-25140000	Active TSS	HUVEC	blood vessel
34	chr6:25139800-25140000	Active TSS	NHEK	skin
35	chr6:25139800-25140200	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
36	chr6:25139800-25140200	Enhancers	Liver	Liver
37	chr6:25139800-25140200	Enhancers	GM12878-XiMat	blood
38	chr6:25139800-25140200	Active TSS	Monocytes-CD14+_RO01746	blood
39	chr6:25139800-25140400	Active TSS	Fetal Lung	lung
40	chr6:25139800-25140400	Active TSS	Pancreas	Pancrea
41	chr6:25139800-25140800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
42	chr6:25140000-25140200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
43	chr6:25140000-25140200	Flanking Active TSS	Ovary	ovary
44	chr6:25140000-25140200	Enhancers	Right Ventricle	heart
45	chr6:25140000-25140600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
46	chr6:25140000-25140600	Enhancers	Dnd41	blood
47	chr6:25140000-25142600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
48	chr6:25140000-25143000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
49	chr6:25140000-25146800	Weak transcription	Primary hematopoietic stem cells	blood
50	chr6:25140000-25146800	Weak transcription	Primary hematopoietic stem cells short term culture	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links